Prescription drug · ANDA
Rivastigmine Tartrate NDC 46708-066
Rivastigmine tartrate 6 mg/1 · Capsule · Oral · Alembic Pharmaceuticals Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 46708-066-10 | 46708006610 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (46708-066-10) / 10 CAPSULE in 1 BLISTER PACK (46708-066-11)Marketed from Jun 13, 2012 | |
| 46708-066-30 | 46708006630 | 30 CAPSULE in 1 BOTTLE (46708-066-30)Marketed from Jun 13, 2012 | |
| 46708-066-60 | 46708006660 | 60 CAPSULE in 1 BOTTLE (46708-066-60)Marketed from Jun 13, 2012 | |
| 46708-066-71 | 46708006671 | 500 CAPSULE in 1 BOTTLE (46708-066-71)Marketed from Jun 13, 2012 | |
| 46708-066-91 | 46708006691 | 1000 CAPSULE in 1 BOTTLE (46708-066-91)Marketed from Jun 13, 2012 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Rivastigmine Tartrate
- Generic name (nonproprietary)
- rivastigmine tartrate
- Active ingredients
- Rivastigmine tartrate — 6 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 091689
- Marketing start
- Listing expires
- Other FDA classes
- Cholinesterase Inhibitors (Mechanism)
- Identifiers
- Product ID 46708-066_1ff4407e-25ad-4fa7-95dd-859e6589d5d1SPL ID 1ff4407e-25ad-4fa7-95dd-859e6589d5d1SPL set ID 33e6a772-382d-45f5-9d45-966c07759367RxCUI 312835, 312836, 314214, 314215UNII 9IY2357JPEUPC 0346708063306, 0346708064303, 0346708065300, 0346708066307
- Pharmacologic class
- Cholinesterase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N446708006610followed by a unit qualifier and the quantityPackage 46708-0066-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Label details couldn’t be retrieved right now. Open the label on DailyMed.
Other NDCs under ANDA 091689
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Rivastigmine Tartrate | Rivastigmine tartrate 1.5 mg/1 | CapsuleOral | Alembic Pharmaceuticals Limited | 46708-063 |
| Rivastigmine Tartrate | Rivastigmine tartrate 3 mg/1 | CapsuleOral | Alembic Pharmaceuticals Limited | 46708-064 |
| Rivastigmine Tartrate | Rivastigmine tartrate 4.5 mg/1 | CapsuleOral | Alembic Pharmaceuticals Limited | 46708-065 |
| Rivastigmine Tartrate | Rivastigmine tartrate 1.5 mg/1 | CapsuleOral | Alembic Pharmaceuticals Inc. | 62332-063 |
| Rivastigmine Tartrate | Rivastigmine tartrate 3 mg/1 | CapsuleOral | Alembic Pharmaceuticals Inc. | 62332-064 |
| Rivastigmine Tartrate | Rivastigmine tartrate 4.5 mg/1 | CapsuleOral | Alembic Pharmaceuticals Inc. | 62332-065 |
| Rivastigmine Tartrate | Rivastigmine tartrate 6 mg/1 | CapsuleOral | Alembic Pharmaceuticals Inc. | 62332-066 |